Literature DB >> 25421689

Specific type epigenetic changes in cervical cancers.

Shuping Zhao1.   

Abstract

Cancer is a genetic and epigenetic disease. Multiple genetic and epigenetic changes have been studied in cervical cancer; however, such changes are selected for during tumorigenesis and tumor aggression is not yet clear. Cervical cancer is a multistep process with accumulation of genetic and epigenetic alterations in regulatory genes, leading to activation of oncogenes and inactivation or loss of tumor suppressor genes. In cervical cancer, epigenetic alterations can affect the expression of papillomaviral as well as host genes in relation to stages representing the multistep process of carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25421689     DOI: 10.1007/978-1-4939-1804-1_38

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

Review 1.  The human papillomavirus oncoproteins: a review of the host pathways targeted on the road to transformation.

Authors:  James A Scarth; Molly R Patterson; Ethan L Morgan; Andrew Macdonald
Journal:  J Gen Virol       Date:  2021-01-11       Impact factor: 3.891

2.  Modulation of DNA methylation by human papillomavirus E6 and E7 oncoproteins in cervical cancer.

Authors:  Prakriti Sen; Pooja Ganguly; Niladri Ganguly
Journal:  Oncol Lett       Date:  2017-10-30       Impact factor: 2.967

3.  Regulatory roles of miRNA-758 and matrix extracellular phosphoglycoprotein in cervical cancer.

Authors:  Xianhua Meng; Yinghui Zhao; Jinyun Wang; Zheng Gao; Qingxia Geng; Xiaoxia Liu
Journal:  Exp Ther Med       Date:  2017-08-04       Impact factor: 2.447

4.  MRVI1 and NTRK3 Are Potential Tumor Suppressor Genes Commonly Inactivated by DNA Methylation in Cervical Cancer.

Authors:  Huihui Ji; Kehan Li; Wenxiao Jiang; Jingwei Li; Jian-An Zhang; Xueqiong Zhu
Journal:  Front Oncol       Date:  2022-01-24       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.